ASEAN MedTech Nisai Partner with KXCO
NISAI Medical has chose to partner with KXCO for the development of there business in the digital world.
KXCO will be involved in the processes of Blockchain, Equity and Bond Issuance as well as taking Nisai Public.
NISAI Medical is a healthcare investment and medical asset management platform powered by blockchain technology. Investments in healthcare and medical assets, while quite profitable, is fragmented and inefficient with high capital requirements making it inaccessible for regular investors. Built on a decentralized ecosystem, the platform will bring transparency and accountability to the medical asset market and contribute new innovations to this traditional industry.
NISAI think healthcare and particularly medical asset financing should not be solely in the hands of middlemen such as banks and that there is tremendous innovation to be made which would ultimately improve medical service networks and help better serve people’s diagnostic and treatment needs. The project is poised to disrupt this field and make it more accessible, transparent, and democratic for the public and the various value chain participants.
NISAI is creating an ecosystem of tokenized healthcare assets that are built and operated with the expertise of Eastern Continents Medical Partners Limited (ECMP).
Those assets function as white-label medical solutions that serve the basic healthcare services of hospitals and medical institutions in Southeast Asia.
The NISAI platform grows on ECMP’s successful track record, and it will catalyze the expansion of ECMP’s already existing network of medical assets.
NISAI offers investors the unique opportunity to own tokens that provide performance-based yield and a stake in the success of the business, thereby enabling investment exposure into the healthcare industry without the usual high-capital entry barrier.
The NISAI token will function as a tool for profit sharing while having substantial utility within the NISAI ecosystem. The tokens will be utilized within the platform by users to access permissioned data and for staking protocols.
Under the name Knightsbridge KXCO became one of Asia’s leading financial services companies with interests in Institutional investment, Private Equity, Capital Markets, Publishing, and Agriculture that span every continent of the world.
USA vs China: The AI and Quantum Scorecard
The US still leads AI models and chips by a whisker; China leads power and open-weight models outright. Shayne Heffernan scores the four races that will decide the decade.
ASEAN: The Next Great AI Superpower
AI is not software; it is infrastructure — power, land, water, fibre and chips. Shayne Heffernan on why Southeast Asia is emerging as the third pole of global AI, where the hyperscalers are building, and how to invest.
Palantir Stock (PLTR): BUY Rating, $250 Price Target — The 40% Dislocation
Palantir is down ~40% in 2026 even as Q1 revenue grew 85% and management guided FY2026 to $7.66B. Shayne Heffernan issues a BUY on PLTR with a $250 price target — full breakdown of the business, customers, five-year revenue, every major Wall Street bank target and the corporate outlook.
Biohacking: The Science of Optimizing Longevity
An evidence-led, optimistic tour of biohacking: what it is, why the science is sound, and how the movement is converging with clinical longevity medicine of the kind practised at Bangkok's Target150.
Every story, signed and delivered.
Subscribe to the kxco channel and get the headline, the AI-written key takeaways, and the chain-anchor link the moment we publish. Audio versions and per-ticker subscriptions arrive in the next iteration.